FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely phthisiology and infectious diseases, and can be used to determine the immune reconstruction syndrome in patients with tuberculosis and HIV infection. The method for determining the inflammatory syndrome of immunity reconstruction in patients with tuberculosis and HIV infection against the background of the use of highly active antiretroviral therapy consists in the fact that the content of triglycerides in the patient's blood is determined and if in a month’s time the level of triglycerides exceeds their level before the beginning of HAART more than 2 times, the presence of the inflammatory syndrome of immune reconstruction in patients with tuberculosis and HIV infection during the use of HAART is determined.
EFFECT: invention improves quality of determining the inflammatory immune reconstruction syndrome in patients with tuberculosis and HIV infection against the background of the use of highly active antiretroviral therapy.
1 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETECTION OF IMMUNE RECONSTITUTION INFLAMMATORY DISEASE IN PATIENTS WITH DRUG-RESISTANT TUBERCULOSIS AND HIV INFECTION WITH UNDERLYING HIGH-ACTIVE ANTIRETROVIRAL THERAPY | 2011 |
|
RU2468801C1 |
METHOD OF TREATING PATIENTS WITH DRUG-RESISTANT TUBERCULOSIS OR HIV-INFECTION | 2011 |
|
RU2482848C1 |
METHOD OF PREDICTING EFFICIENCY OF ANTIRETROVIRAL THERAPY IN CASE IN HIV-INFECTION | 2009 |
|
RU2414858C1 |
METHOD FOR PREDICTING THE EFFECTIVENESS OF ANTIRETROVIRAL THERAPY FOR CO-INFECTION WITH TUBERCULOSIS AND HIV INFECTION | 2017 |
|
RU2666223C1 |
METHOD OF ASSESSMENT THE SEVERITY OF A PATIENT'S CONDITION AT HIV INFECTION | 2017 |
|
RU2670652C2 |
METHOD OF TREATING EPSTEIN-BARR VIRAL INFECTION IN HIV-INFECTED CHILDREN | 2014 |
|
RU2555474C1 |
METHOD FOR PREDICTION OF STABLE VIROLOGICAL RESPONSE TO ANTI-VIRAL THERAPY OF CHRONIC VIRAL HEPATITIS C ACCOMPANYING HIV INFECTION | 2013 |
|
RU2558793C2 |
METHOD OF PREDICTING PROGRESSION OF HIV INFECTION IN PATIENTS RECEIVING ANTIRETROVIRAL THERAPY | 2019 |
|
RU2697392C1 |
METHOD OF TREATING CHRONIC HEPATITIS IN HIV POSITIVE PATIENTS | 2009 |
|
RU2412699C1 |
METHOD FOR ASSESSING RISK OF BACTERICIDAL COMPLICATIONS IN PATIENTS WITH HIV INFECTION DURING OPIOID WITHDRAWAL SYNDROME | 2021 |
|
RU2756871C1 |
Authors
Dates
2021-03-18—Published
2020-07-28—Filed